In Quitting smoking Nocrav 1mg Tablet is a medicine used, along with social support and counseling, to help people quit smoking and to prevent an urge to smoke again. Nocrav 1mg Tablet starts working from the very first dose and is a very safe and effective way of treating smoking addiction.
It is unsafe to consume alcohol with Nocrav 1mg Tablet.
Nocrav 1mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Nocrav 1mg Tablet should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Nocrav 1mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Nocrav 1mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Nocrav 1mg Tablet may be needed. Please consult your doctor.
Nocrav 1mg Tablet is safe to use in patients with liver disease. No dose adjustment of Nocrav 1mg Tablet is recommended.
If you miss a dose of Nocrav 1mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More